Little is known about a possible interaction of natural killer (NK) cells with regulatory T cells (T reg ) in long-term stable kidney transplant recipients. Absolute counts of lymphocyte and T reg subsets were studied in whole blood samples of 136 long-term stable renal transplant recipients and 52 healthy controls using eight-colour fluorescence flow cytometry. Patients were 1946 6 2201 days (153-10 268 days) post-transplant and showed a serum creatinine of 1Á7 6 0Á7 mg/dl. Renal transplant recipients investigated > 1Á5 years post-transplant showed higher total NK cell counts than recipients studied < 1Á5 years after transplantation (P 5 0Á006). High NK cells were associated with high glomerular filtration rate (P 5 0Á002) and low serum creatinine (P 5 0Á005 
Summary
Little is known about a possible interaction of natural killer (NK) cells with regulatory T cells (T reg ) in long-term stable kidney transplant recipients. Absolute counts of lymphocyte and T reg subsets were studied in whole blood samples of 136 long-term stable renal transplant recipients and 52 healthy controls using eight-colour fluorescence flow cytometry. Patients were 1946 6 2201 days (153-10 268 days) post-transplant and showed a serum creatinine of 1Á7 6 0Á7 mg/dl. Renal transplant recipients investigated > 1Á5 years post-transplant showed higher total NK cell counts than recipients studied < 1Á5 years after transplantation (P 5 0Á006). High NK cells were associated with high glomerular filtration rate (P 5 0Á002) and low serum creatinine (P 5 0Á005). Interestingly, high NK cells were associated with high CD4 1 CD25 1 HLA-DR 1 (P < 0Á001), CD95 1 CD178 -(P < 0Á001) and CD279 -CD152 1 (P < 0Á001),
suggesting that these activated T reg home in peripheral tissues and suppress effector cells via TGF-b and cytotoxic T lymphocyte-associated protein 4 (CTLA-4). The higher numbers of NK and T reg cell counts in patients with long-term good allograft function and the statistical association of these two lymphocyte subsets with each other suggest a direct or indirect (via DC) interaction of these cell subpopulations that contributes to good long-term allograft acceptance. Moreover, we speculate that regulatory NK cells are formed late post-transplant that are able to inhibit graft-reactive effector cells.
Introduction
The role of natural killer (NK) cells in solid organ and bone marrow transplantation remains somewhat unclear [1, 2] . NK cells are thought to represent cytotoxic effector cells involved in immune responses against virus, tumour cells and allografts [3] [4] [5] . Additionally, immunoregulatory NK cells with phenotype and cytokine patterns different from cytotoxic effector NK cells have been described, and are thought to be involved in successful pregnancy [4, [6] [7] [8] .
Biomarkers associated with tolerance following kidney transplantation are dominated by increases in peripheral B cell numbers and the expression of B cell-related genes in blood lymphocytes, as well as defects in B cell maturation and evidence of active suppression mediated by B cells in vitro, as reviewed by Newell and Turka [9] . Sagoo et al.
reported that tolerant renal transplant recipients displayed an expansion of peripheral blood B and NK lymphocytes, reduced activated CD4 1 T cells, a lack of donor-specific antibodies, donor-specific hyporesponsiveness of CD4 1 T cells and a high ratio of forkhead box P3 (FoxP3) to alpha-1,2-mannosidase gene expression [10] . In addition, biomarkers associated with tolerance following liver transplantation are related predominantly to NK cells and gd T cells in the blood and genes related to iron homeostasis within the graft [9] . Tolerant recipients display an increased proportion of NK cells and a decreased proportion of Vd2 gd T cells in their peripheral blood [9] . An increase in the proportion of CD4 1 CD25 1 CD127 -FoxP3 1 T cells in the blood was also noted, albeit only 12 months following discontinuation of immunosuppression [9] . Control of NK cell function by CD4
1

CD25
1 regulatory T cells was observed in several studies [11] . Toll-like receptor (TLR)29-engaged plasmacytoid dendritic cells (DC) represent a critical stimulus for human NK cells, and CD4
1 T helper cells (Th) cells and CD4
1 CD25 hi regulatory T cells (T reg ) play an important role in modulating human NK cell responses [12] . Jukes et al. reported on a bystander activation of invariant NK (iNK) T cells that occurs during conventional T cell alloresponses [13] . In the setting of haematopoietic stem cell transplantation, murine and human in-vitro experiments support the assertion that T reg antagonize NK responses [2] . Some studies support an augmented NK cell response in the absence of T reg , as reviewed by Verneris [2] . Others reported that murine NK cells delay allograft rejection in lymphopenic hosts by down-regulating the homeostatic proliferation of CD8 1 T cells [14] . In haemodialyzed and kidney transplanted patients, innate-like and conventional T cell populations were shown to be equally compromised [15] . PadrozaPacheco et al. reviewed the interaction between NK cells and T reg for future perspectives of immunotherapy [16] .
In the present study, several T reg subsets were analysed [17] [18] [19] [20] [21] . Signalling through interferon (IFN)-gR and interleukin (IL)212R, in combination with T cell receptor (TCR) engagement, induces strong expression of the transcription factor T-bet, which drives the differentiation of conventional T cells to a Th1 lineage [22] . Up-regulation of the transcription factor Helios modulates and stabilizes FoxP3 expression [23] [24] [25] [26] [27] [28] [29] [30] . Helios is expressed on the majority of thymus-derived T reg (tT reg ) [31] ; however, part of the tT reg lack Helios expression [32] . Peripherally induced T reg (pT reg ) do not express Helios [31] , but are able to up-regulate Helios in combination with FoxP3 during cell activation [33, 34] . Thymic tT reg were shown to have stable FoxP3 expression in contrast to peripherally induced pT reg presenting FoxP3 only transiently, with the risk of reprogramming from T reg to Th1 effector cells [19, 35] . McClymont et al. reported that the majority of invitro-induced IFN-g 1 T reg did not express Helios, suggesting that they were generated extra-thymically [36] . Alternatively, they might belong to a minority of Helios -tT reg expressing FoxP3, CD39, cytotoxic T lymphocyteassociated protein 4 (CTLA-4), CCL3 and IFN-g, as published by Himmel et al. [32] . Further experiments showed that tT reg can polarize towards IFN-g 1 T cells in-vitro by interleukin (IL)212 conditioning, whereby they remain Helios 1 , suggesting that part of the thymic-derived T reg population exhibits plasticity in cytokine production and expresses a Th1-like phenotype [36] . As shown in the blood of healthy individuals, Helios 1 IFN-g 1 T reg co-express TGF-b but not IL-10. Further analysis of T reg phenotypes showed that T reg co-expressed granzyme B and perforin inaddition, as well as Fas (CD95) and FasL (CD178), thereby affording the T reg the capacity to induce lysis and apoptosis of target cells [37] . Moreover, expression of CTLA-4 (CD152) and CD40L (CD154) imply cell-cell contactdependent immunosuppression by these T reg subsets. CXCR3 and CD62L expression suggests that part of these cells have the potential to enter secondary lymphoid organs as well as inflamed tissues [38, 39] . These T reg exhibit Th1 characteristic properties such as IFN-gR1 (CD119) and Tbet expression, which means they have the potency to regulate expression as well as consumption of IFN-g in the cell. CD28 is involved in T reg activation and human leucocyte antigen D-related (HLA-DR) expression indicates activation of T reg [40] .
A possible relationship or interaction of NK cells and T reg in renal transplant recipients has not been examined previously. In the present study, we looked for a possible association of NK cells with certain T reg subsets in patients with good long-term renal allograft acceptance. If evidence for such an association could be found, it would suggest a direct or indirect (via DC) immunoregulatory interaction of these two lymphocyte subpopulations.
Methods
Healthy controls and patients
Laboratory staff served as healthy controls. All controls (n 5 52) and renal transplant recipients (n 5 136) gave informed consent for the tests performed within this study and the study was approved by the local ethical committee (S-225/2014). The study was conducted in adherence to the Declaration of Helsinki. The mean age of patients was 49 6 13 years (range 5 19-76 years) and that of healthy controls was 41 6 12 (range 5 20-60) years (Table 1) . Patients were 1946 6 2201 days (range 5 153-10 268 days) post-transplant and showed a glomerular filtration rate (GFR) of 48 6 20 ml/min (range 5 11-111 ml/min) and a serum creatinine of 1Á7 6 0Á7 mg/dl (range 5 0Á7-4Á6 mg/ dl) (Fig. 1) . Blood for the tests was obtained during regular routine investigations in the out-patient clinic. At the time of testing, the patients showed no signs of acute rejection or infection. All patients received standard immunosuppression, consisting of combinations of cyclosporin A, tacrolimus, steroids, mycophenolate mofetil or azathioprine ( Table 1) .
Determination of lymphocyte subpopulations
Because the combination of phycoerythrin-labelled CD16 and CD56 monoclonal antibody was used, peripheral blood levels of total NK cells included CD16
1 CD56 1 ,
CD16
-CD56 1 and CD16 1 CD56 -subpopulations of NK cells [18] . In detail, using four-colour fluorescence flow cytometry CD45 
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V C 2017 British Society for Immunology, Clinical and Experimental Immunology, 188: 467-479 fluorescein isothiocyanate, phycoerythrin, allophycocyanin or peridinin-chlorophyll-protein complex were added to 50 ml of heparinized whole blood and incubated for 15 min at room temperature. Erythrocytes were lysed with NH 4 Cl for 15 min. Lymphocyte subsets were analysed using a fluorescence-activated cell sorter (FACS)Calibur flow cytometer (BD Biosciences, Heidelberg, Germany). The flow cytometer was calibrated every day using CaliBRITE beads (BD Pharmingen) to ensure optimal counting.
Determination of different T reg subsets
T reg subsets were determined as described previously [21] . The exact gate settings of the present study are depicted in . Briefly, PBL were incubated with combinations of monoclonal antibodies for 30 min as described and eight-colour fluorescence was analysed using a FACSCanto II triple-laser flow cytometer (BD Biosciences). When, in addition, intracellular proteins were studied, cell membranes were permeabilized using BD perm/wash buffer (BD Biosciences). At least 100 000 events were analysed in the initial forward-/side-scatter (FSC/SSC) dotplot. Total CD4 
Statistical analysis
For statistical analysis, PASW statistics program version 21 (IBM, Chicago, IL, USA), Spearman's rank correlation and Mann-Whitney U-tests were used. P-values < 0Á01 after Bonferroni's correction were considered significant. Simple linear regression was conducted first to determine the influence of NK cells, CD8
1 and CD4 1 T and CD19 1 B lymphocytes on different T reg subsets in univariate analysis. Thereafter, and before running multivariate regression analysis, cell subset distributions were explored and logtransformed when necessary to meet the criteria of this analysis. A backstep elimination model was used in which variables that produced P-values < 0Á05 were considered.
Results
Demographic data are summarized in Table 1 and the panels of lymphocyte and CD4 1 CD25 1 FoxP3 1 CD127 -T reg subsets analysed are shown in Table 2 .
Lymphocyte and T reg subsets in patients and healthy controls
Compared to healthy controls, the patients with wellfunctioning grafts showed lower relative and absolute counts of CD19
1 B lymphocytes (both P < 0Á001; Mann-Whitney U-test), indicating a B lymphocyte deficiency in patients. Moreover, the patients showed decreased absolute counts of total CD45 1 lymphocytes and total NK cells (both P < 0Á001) and CD3 1 and CD4 1 T lymphocytes (both P 5 0Á001), but similar absolute counts of CD8 1 T effector cells (P 5 0Á045) ( Table 2 ). The data suggest that CD8 1 T lymphocytes are decreased only marginally late posttransplant in patients, whereas other T, B and NK cell subsets are reduced significantly compared to healthy individuals. Compared to healthy controls, patients showed significantly decreased absolute counts of total CD4 1 CD25
Helios
1
T reg (P 5 0Á007), whereas IFN-g 1 Helios -T reg were similar in patients and controls (P 5 0Á586). When additional subsets of CD4 1 CD25 1 FoxP3 1 CD127 -T reg were analysed, patients showed lower
(P 5 0Á001) than healthy controls (Table 2 ). It appears that activated T reg with homing receptors for lymph nodes and receptors for B lymphocyte and DC interaction are reduced in patients, whereas other T reg subsets expressing IL-10, TGFb, CD178, CD119, T-bet, granzyme and/or perforin are present at similar levels as those found in healthy controls (P > 0Á01) ( Table 2) .
Stability of lymphocyte and T reg subsets in patients
To study the stability of lymphocyte counts and T reg phenotypes, lymphocyte and T reg subsets were studied twice in 59 patients [interval first versus second investigation: 120 6 47 days; mean 6 standard deviation (s.d.)] and three times in 11 patients (interval second versus third investigation: 106 6 19 days). Only CD951CD178 -(first versus second investigation: 2Á6 6 2Á3/ml versus 1Á9 6 1Á7/ml; P 5 0Á004; Wilcoxon's signed rank test) and perforin 1 granzyme B 1 (second versus third investigation: 3Á0 6 5Á3/ml versus 4Á1 6 6Á7/ml; P 5 0Á008) absolute T reg numbers differed among the measurements (data not shown).
NK cells and Tregs in renal transplantation
NK cells and time post-transplant
When lymphocyte and T reg subsets in patients 1Á5 versus > 1Á5 years post-transplant (n 5 39 versus n 5 97) were compared, only total NK cells were higher in patients > 1Á5 years post-transplant (124 6 107/ml versus 181 6 140/ml; P 5 0Á006; Mann-Whitney U-test), whereas the other lymphocyte and T reg subsets were similar (data not shown). Patients 1Á5 years post-transplant were analysed after a mean follow-up of 13 6 3Á1 months post-transplant (range 5 5-18 months) and patients >1Á5 years posttransplant after a follow-up of 90 6 83 months (range 5 20-360 months) ( Table 1) . 
CD25
1 FoxP3
Helios
-T reg /ml 0 Á08 6 0Á18 0Á09 6 0Á16 0Á586 IL-10
*Mann-Whitney U-test: patients versus healthy individuals. All data are given as mean 6 standard deviation (s.d.). P-values < 0Á01 were considered significant (Bonferroni correction). HLA-DR 5 human leucocyte antigen D-related; FoxP3 5 forkhead box protein 3; IL5 interleukin; IFN 5 interferon; TGF 5 transforming growth factor; NK 5 natural killer.
Graft function and lymphocyte/T reg counts
Patients had a mean GFR of 48 6 20 ml/min (6 s.d.) and a mean serum creatinine of 1Á7 6 0Á71 mg/dl. Both higher GFR and lower serum creatinine were associated with higher total NK and CD19 
FoxP3
1 T reg that co-express the phenotypes IL-
and CD279 -CD152 1 (P < 0Á001) ( T lymphocytes remained significant in multivariate analysis (beta-coefficient 5 0Á33, P < 0Á001). In healthy individuals these associations were absent (P 5 0Á859; P 5 0Á804; P 5 0Á235; and P 5 0Á070, respectively) ( Table 4 ). The data suggest that CD8 1 T lymphocyte counts are associated independently with CD4 1 T lymphocyte counts in immunosuppressed patients with well-functioning grafts.
Immunosuppressive protocol and lymphocyte/T reg counts
We studied whether treatment with certain immunosuppressive drugs was associated with certain lymphocyte and T reg counts. Patients with higher daily steroid doses also received higher azathioprine doses (r 5 0Á806, P 5 0Á009; Spearman's rank correlation test), and patients with higher tacrolimus doses tended to receive, in addition, higher mycophenolate doses (r 5 0Á343, P 5 0Á003). Interestingly, steroids (n 5 82), cyclosporin (n 5 20), tacrolimus (n 5 104) and mycophenolate mofetil (n 5 91) doses did not show significant associations with absolute numbers of T and B lymphocytes, NK cells or T reg subsets. In contrast, high azathioprine doses were associated with low
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V C 2017 British Society for Immunology, Clinical and Experimental Immunology, 188: 467-479 Table 3 . Association of glomerular filtration rate (GFR) with lymphocyte and regulatory T cell (T reg ) subsets in 136 transplant recipients GFR Creatinine Parameter P r P r
Total NK/ml (CD16
All parameters of Table 2 were analysed using Spearman's rank correlation test. Only parameters showing P-values of P < 0Á01 with both GFR and serum creatinine are shown in Table 3 . HLA-DR 5 human leucocyte antigen D-related; NK 5 natural killer. Subset/ml r P r P r P r P
Statistical analysis was performed using Spearman's rank correlation test. P-values of <0Á02 were marked by colours and correlations of CD8 absolute counts of total NK cells (n 5 15; r 5 -0Á775, P < 0Á001). Interestingly, when patients with or without steroid therapy were compared, patients on steroids had higher CD28
1 HLA-DR -(P 5 0Á005) and lower CD28 -HLA-DR 1 (P 5 0Á002) and CD279 1 CD152 -T reg (P 5 0Á008) counts than steroid-free patients (n 5 49)Á The other cell subsets were similar in patients on steroidcontaining or steroid-free immunosuppressive maintenance. Blood levels of cyclosporin (n 5 20 patients), tacrolimus (n 5 104) and mycophenolate mofetil (n 5 44) were not associated significantly with lymphocyte and T reg subset counts.
Immunosuppressive protocol and GFR
There was no association of GFR with daily oral drug dose or blood level of immunosuppressive drugs.
Immunosuppressive drugs, lymphocyte and T reg subsets and time post-transplant
Daily mycophenolate mofetil (r 5 -0Á319; P 5 0Á002; Spearman's rank correlation test) and tacrolimus doses (r 5 -0Á290; P 5 0Á003) as well as mycophenolate blood levels (r 5 -0Á486; P 5 0Á001) were decreased with time post-transplant, and CD28 -HLA-DR 1 T reg counts (r 5 0Á300; P < 0Á001) increased simultaneously.
Rejection and lymphocyte/T reg subsets
Ninety-three patients never experienced rejection, nine had experienced a rejection Banff grade > 1 prior to testing, and 16 had experienced previous borderline rejection. All rejections were reversed and all patients had wellfunctioning kidney grafts at the time of testing. Lymphocyte and T reg subsets were not significantly different in the three patient groups. Fig. 3 . Associations of total natural killer (NK) cell counts with graft outcome and regulatory T cell (T reg ) subset counts in long-term stable renal transplant recipients. Absolute counts of total NK cells were associated with glomerular filtration rate (r 5 0Á263; P 5 0Á002; Spearman's rank test) and serum creatinine (r 5 -0Á241; P 5 0Á005) as well as absolute total T reg (r 5 0Á347; P < 0Á001) and Helios
counts (r 5 0Á339; P < 0Á001) in long-term stable renal transplant recipients (n 5 136). Infection and lymphocyte/T reg subsets
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Patients were free of acute infection at the time of testing. Six patients had experienced viral infections and 25 bacterial infections more than 3 months prior to testing. Previous viral infection was not associated with lymphocyte and T reg subsets (P > 0Á01; Mann-Whitney U-test), whereas previous bacterial infection was associated with increased IL-10
Discussion
In the present study, we investigated whether there is an association of NK cells with T reg subsets in peripheral blood in kidney recipients with good long-term allograft outcome. Peripheral blood levels of total NK cells included CD16
-subpopulations of NK cells. Our data suggest that NK cell counts increase with time post-transplant in patients with good graft outcome. When lymphocyte and T reg subsets in patients 1Á5 versus > 1Á5 years post-transplant were compared, only total NK cells were higher in patients > 1Á5 years post-transplant, whereas the other lymphocyte and T reg subsets were similar. The long-term NK cell increase was associated neither with daily doses of immunosuppressive drugs or blood levels of immunosuppressants nor with the occurrence of acute infection or rejection. We found evidence to suggest that NK cell counts increase independently in parallel with T reg counts, particularly Helios 1 IFNg -thymus-derived tT reg . This particular T reg subset coexpresses the activation marker HLA-DR and appears to affect effector cells functionally by release of TGF-b or via CTLA-4-mediated cell interaction with DC in lymph nodes. These associations were observed in transplant patients, but not in healthy individuals. We therefore speculate that whereas healthy controls have stable NK cells counts, NK cell and T reg counts increase with time posttransplant in patients with good graft function and direct or indirect (via DC) interaction of these cell subsets may prevent graft damage by the innate immune system. The stimulus for the NK cell increase remains unknown. Interestingly, CD8
1 lymphocytes did not show a similar increase post-transplant; these cells were associated strongly with activated HLA-DR expressing T reg that coexpress apoptosis-inducing substances and determinants such as perforin, granzyme B and Fas ligand. One might speculate that graft-specific CD8 1 lymphocytes were killed by cytotoxic T reg , thereby preventing increases of CD8 and potentially inhibit NK cell function [43] . Our finding of a strong association of TGF-b-producing T reg with NK cell numbers suggests that T reg might inhibit NK cells in renal transplant recipients directly by release of TGF-b. Others reported that NK T cells promoted changes in expression of negative co-stimulatory receptors and antiinflammatory cytokines by T reg and other T cell subsets in an IL-4-dependent manner, an effect that resulted in tolerance to bone marrow and organ grafts in animals [44] . Additionally, NK cells are involved both in rejection and tolerance of solid allografts, as reviewed by Benichou et al. [45] . Allo-NKs were reported to be capable of inducing systemic tolerance after haplo-haematopoietic stem cell transplantation (HSCT) by assembling donor-derived immature DCs to expand recipient-derived T reg cells in the thymus [46] . Our finding of a strong association of CD152 1 T reg with NK cell numbers in renal transplant recipients suggests that T reg might inhibit NK cells via negative signalling to DC that (a) might inhibit NK cells by release of immunosuppressive cytokines or negative signals during cell-cell contact, or (b) might induce further T reg . In kidney transplant patients, down-modulation of CD16 and CD6 on CD56 (dim) NK cells was observed, with significant differences between cyclosporin A-and tacrolimus-treated patients [47] . Tacrolimus treatment was associated with decreased CD69, HLA-DR and increased CD94/NKG2A expression in CD56 (dim) NK cells, indicating that the quality of immunosuppressive treatment impinges upon the peripheral NK cell repertoire. In-vitro studies with peripheral blood mononuclear cells of healthy donors showed that this modulation of CD16, CD6, CD69 and HLA-DR could also be induced experimentally. The presence of calcineurin or mTOR inhibitors had also functional consequences regarding degranulation and IFN-g production against K562 target cells, respectively [47] . Furthermore, Bergmann et al. concluded from in-vitro experiments that human tumour iT reg cells inhibited IL-2-mediated NK cell activity in the absence of target cells, whereas, surprisingly, the tumoricidal activity of NK cells was enhanced by iT reg cells [48] . Gasteiger et al. reported that CD127
1 NK cells expanded in an IL-2-dependent manner upon T reg cell depletion and were able to give rise to mature NK cells, indicating that the latter can develop through a CD25 1 intermediate stage [49] . Thus, T reg cells restrain the IL-2-dependent CD4 1 T cell help for CD127 1 immature NK cells. These findings highlight the adaptive control of innate lymphocyte homeostasis [49] . The same authors reported that IL-2 rapidly boosted the capacity of NK cells to engage target cells productively and enabled NK cell responses to weak stimulation [50] . The results suggest that IL-2-dependent adaptive-innate lymphocyte cross-talk tunes NK cell reactivity and that T reg cells restrain NK cell cytotoxicity by limiting the availability of IL-2 [50] . The IL-2 dependence of T reg /NK cell interaction was confirmed in a murine diabetes model. Results from gene signature analyses, quantification of signal tranducer and activator of transcription (STAT)25 phosphorylation levels, cytokine neutralization experiments, cytokine supplementation studies and evaluations of intracellular cytokine levels argue collectively for a scenario in which T reg regulate NK cell functions by controlling the bioavailability of limiting amounts of IL-2 in the islets, generated mainly by infiltrating CD4 1 T cells [51] . Moreover, Jukes et al. reported that iNK T cells are not activated by allogeneic cells per se, but expand, both in-vitro and in-vivo, in the presence of a concomitant conventional T cell response to alloantigen that is triggered by IL-2 [13] . Our finding of an association of DR
1
Helios IFN-g -T reg with NK cell numbers suggests that most of the T reg might have stable FoxP3 expression, originate from the thymus and therefore do not produce IL-2 by themselves, and that these DR 1 T reg are activated and consume IL-2, resulting in IL-2-dependent inhibition of NK cells. Immunosuppressive drugs such as cyclosporin and tacrolimus that inhibit IL-2 production in lymphocytes can therefore contribute indirectly to NK cell suppression in renal transplant recipients.
In general, the cited experiments in animals and cell cultures as well as the observations in clinical haematopoietic stem cell transplantation suggest that T reg interact directly or via DC with NK cells, with the potential to downregulate cytotoxic or to enhance immunoregulatory NK cell function. These observations agree with our finding that high NK cell counts are associated with high CD152 1 T reg that might transform immunostimulatory DC to immunosuppressive NK cell-inhibiting DC. TGF-bproducing T reg might suppress NK cells directly. Strongly activated thymical-derived T reg might inhibit NK cells by IL-2 consumption. Our data suggest that NK cells might interact with T reg in lymph nodes.
Moreover, we speculate that renal transplant recipients > 1Á5 years post-transplant develop an immunoregulatory NK cell type with diminished natural cytotoxicity and little IFN-g production upon monokine stimulation [52] , similar to those immunoregulatory NK cells in the uterus that protect pregnancy [4, 53] . Immunoregulatory NK cells (NK reg ) have been demonstrated in vitro [54, 55] , and these NK reg were able to suppress T cell responses antigenspecifically in cell culture experiments [55] . The hypothesis that late post-transplant NK reg in combination with T reg and B reg are generated is in line with our finding of high NK, B and T reg cells in patients with good long-term graft function and low immunosuppression, and is supported by reports of high NK, B and T reg cells in tolerant kidney and liver transplant recipients [9, 10, 56, 57] . Our data suggest that induction of NK, B and T reg cells is a phenomenon late post-transplant that is associated with good long-term graft outcome and could be interpreted as an induction of NK, B and T lymphocytes with immunoregulatory function that might inhibit NK, B and T lymphocytes with effector function against the graft.
Conclusions
The higher numbers of peripheral NK cells late posttransplant compared to early post-transplant, the strong association of NK cells with T reg and the strong association of graft function with high NK, T reg and B cell counts in kidney recipients with good long-term graft function suggest an interaction of these cell subpopulations that contributes to good long-term allograft acceptance. Further invitro studies are required to illuminate the mechanisms of NK/B/T reg cell interaction in this particular patient cohort.
Limitations of the study
We studied only statistical associations showing good stable long-term graft function in patients with high NK, B and T reg cells. Further studies investigating phenotype and invitro function of these lymphocyte subsets will clarify whether subsets with an immunoregulatory phenotype are induced, whether these subsets are able to interact with each other and whether they inhibit graft-reactive effector cells.
